Thomas Madden | BiotechTV

top of page

9 hours ago

Acuitas Therapeutics is a pioneer in developing lipid nanoparticles, and already has seen two approved products: ONPATTRO and the Pfizer/BioNTech mRNA vaccine

Co-Founder & CEO Thomas Madden describes the science and history behind LNPs, and discusses what is currently in development, including...

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

At Savills, the Life Sciences Team specializes in helping biotech companies unlock their full potential by aligning real estate strategies with their scientific and business goals. As a leading global commercial real estate advisory firm, we focus exclusively on occupier services and tenant representation, acting as a trusted partner to some of the most innovative companies in the industry.

Visit Savills' Life Sciences Overview

bottom of page

Acuitas Therapeutics is a pioneer in developing lipid nanoparticles, and already has seen two approved products: ONPATTRO and the Pfizer/BioNTech mRNA vaccine

Follow BiotechTV

Sponsors

Sponsor Spotlight